Literature DB >> 3881999

Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry.

.   

Abstract

The Task Force examines the present status of studies investigating the relationship between blood plasma concentrations of tricyclic antidepressants and clinical outcome. It discusses some of the discrepancies that have developed among various antidepressant drugs and evaluates the clinical implications of the current status of blood level monitoring. The Task Force concludes that plasma level measurements of imipramine, desmethylimipramine, and nortriptyline are unequivocally clinically useful in certain situations, that these measurements are helpful in many situations, and that plasma level measurements are likely to grow in usefulness.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881999     DOI: 10.1176/ajp.142.2.155

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  27 in total

Review 1.  Therapeutic drug monitoring of psychotropic medications.

Authors:  P B Mitchell
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

Review 2.  Pharmacological treatment of depression in children and adolescents.

Authors:  R L Findling; M D Reed; J L Blumer
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

3.  Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression.

Authors:  Sven Ulrich; Jürgen Läuter
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Monitoring tricyclic antidepressant therapy.

Authors:  M V Rudorfer
Journal:  Pharmacoeconomics       Date:  1992-02       Impact factor: 4.981

5.  Self-inhibiting action of nortriptyline's anti-immobility effect at high plasma and brain levels in mice.

Authors:  I Reis de Oliveria; B Diquet; V Van der Meersch; R Dardennes; J Gonidec; P A do Prado-Lima
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 6.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  "There is no dose-response relationship in psychopharmacotherapy" vs "pharmacotherapy in psychiatry is based on ligand-receptor interaction": a unifying hypothesis and the need for plasma concentration based clinical trials.

Authors:  Vincent Eggart; Christoph Hiemke; Gerald Zernig
Journal:  Psychopharmacology (Berl)       Date:  2011-05-04       Impact factor: 4.530

Review 8.  Depression in the elderly: the role of the primary care physician in management.

Authors:  J F McGreevey; K Franco
Journal:  J Gen Intern Med       Date:  1988 Sep-Oct       Impact factor: 5.128

Review 9.  Drug therapy for geriatric depression.

Authors:  R Bressler; M D Katz
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

10.  Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.

Authors:  H Giedke; H Gaertner; U Breyer-Pfaff; W Rein; D Axmann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.